Insider Stock Trading History of Bahcall Safi R


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bahcall Safi R since year 2005. The trader's CIK number is 1325719. At the time of this reporting, Bahcall Safi R is the President and CEO of Synta Pharmaceuticals Corp . (stock ticker symbol SNTA). See this page for all insider trading activities at Synta Pharmaceuticals Corp .


Stock purchases, sales, and option exercises reported by insider Bahcall Safi R since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-11-13 SNTA Synta Pharmaceuticals Corp Buy 20,000 3.75 75,000
2013-06-28 SNTA Synta Pharmaceuticals Corp Buy 10,000 5.03 50,300
2013-06-21 SNTA Synta Pharmaceuticals Corp Buy 20,000 4.12 82,380
2013-06-14 SNTA Synta Pharmaceuticals Corp Buy 10,000 4.06 40,550
2013-06-06 SNTA Synta Pharmaceuticals Corp Buy 10,000 4.04 40,390
2012-11-12 SNTA Synta Pharmaceuticals Corp Buy 10,000 7.12 71,200
2012-06-29 SNTA Synta Pharmaceuticals Corp Buy 10,000 5.34 53,370
2011-03-15 SNTA Synta Pharmaceuticals Corp Buy 5,000 4.45 22,250
2010-06-10 SNTA Synta Pharmaceuticals Corp Buy 10,000 3.05 30,530
2010-01-08 SNTA Synta Pharmaceuticals Corp Buy 22,222 4.50 99,999
2009-08-06 SNTA Synta Pharmaceuticals Corp Buy 20,000 2.84 56,720
2007-11-26 SNTA Synta Pharmaceuticals Corp Buy 5,000 7.83 39,140

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bahcall Safi R (President and CEO of Synta Pharmaceuticals Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.